Screener
Cytek Biosciences, Inc. CTKB Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$6.1M-11.3% | -$12.16M-118% | -$18.87M-65.5% | -$44.08M— | -$5.48M-682% | ||
| $2.11M+10.2% | $2.01M+6.3% | $1.87M-0.5% | $1.9M+2.3% | $1.92M+3.6% | ||
| $4.85M-13.9% | $5.34M-21.4% | $4.86M-26.7% | $5.53M-21.1% | $5.64M-20.1% | ||
| -$4.45M-14.2% | —— | -$2.74M-2,089% | -$771K-139% | -$3.9M-129% | ||
| $1.51M+129% | $2.22M+40.5% | $2.17M+155% | $1M+12.0% | $657K-35.0% | ||
| -$1.8M-110% | —— | -$27.08M-386% | —— | $18.92M+220% | ||
| $0— | $0-100% | $0-100% | —— | —— | ||
| $1.06M-49.3% | $41K-97.0% | $5.07M+634% | $1.42M-49.2% | $2.09M+41,720% | ||
| $2.37M+1,531% | $1.61M+1,036% | $869K-42.8% | $2.94M+2,015% | $145K+3.6% | ||
| —— | —— | $3.98M+134% | -$1.23M+66.3% | —— | ||
| -$6.66M— | —— | -$25.19M-631% | -$2.43M+96.2% | —— | ||
| -$5.96M-30.8% | -$849K+42.2% | -$4.9M-403% | -$1.77M-261% | -$4.56M-137% |
FAQ
- What is Cytek Biosciences, Inc.'s free cash flow?
- After $6.9M of capital expenditures, Cytek Biosciences, Inc.'s free cash flow was -$13.5M over the trailing twelve months, down 128.7% year over year.
- Where does Cytek Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cytek Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
